PREXXARTAN is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Medicure International Inc.. The primary component is Valsartan.
| Product ID | 25208-100_7ad4ad18-919e-48fe-b630-213ead75a8b6 |
| NDC | 25208-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PREXXARTAN |
| Generic Name | Prexxartan |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-01-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209139 |
| Labeler Name | Medicure International Inc. |
| Substance Name | VALSARTAN |
| Active Ingredient Strength | 4 mg/mL |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-01-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209139 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-01-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA209139 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-01-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA209139 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-01-02 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| VALSARTAN | 4 mg/mL |
| SPL SET ID: | df73d781-65d8-4aaa-9b0f-de4341f639ec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PREXXARTAN 98875944 not registered Live/Pending |
Carmel Biosciences, Inc. 2024-11-27 |
![]() PREXXARTAN 97328326 not registered Live/Pending |
ECI Pharmaceuticals, LLC 2022-03-24 |
![]() PREXXARTAN 88831554 not registered Live/Pending |
John Copanos 2020-03-12 |
![]() PREXXARTAN 87371806 not registered Live/Pending |
Copanos, John 2017-03-15 |